Reach Us +1-947-333-4405


Interview | Tao LinnbspJournal of Clinical and Experime
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Google scholar citation report
Citations : 1147

Journal of Clinical & Experimental Pathology received 1147 citations as per google scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page
Tao Lin
Tao Lin

Tao Lin
Department of Pathology & Laboratory Medicine
University of Texas
Tel: 713-500-5350
Fax: 713-500-0730
Read Interview session with Tao Lin


Tao Lin is a Associate Professor for Pathology & Laboratory Medicine, University of Texas Medical School at Houston

Research Interest

Bacteria genetics; Bacteria pathogenesis; Functional genomics; Metagenomics; Emerging tick-transmitted disease; Pathogenomics

1. How many years have you been practicing and/or performing research?
33 years.

2. What is the research topic you are working on now?
Functional gemomics, pathogenomics, metagenomics, pathogenesis of infectious diseases, molecular microbiology, immunology.

3. What makes an article top quality?
Solve the important issues in the field using novel ideas and novel technique, make the field forward.

4. What are the qualities you look for in an article?
High scientific standard, move the field forward, application of novel technique.

5. Do you have any research funding (NIH or other national funding) now?
Yes, I have one R01 and R21.

6. When did you become an editor of OMICS Journal?
By invitation.

7. What is your greatest career accomplishment?
I created sequence defined high density signature tagged mutagenesis library in B. burgdorferi, screening and found several hundreds of the virulence determinants using mouse infection model and Luminex FlexMap technique that developed by me. This breakthrough moves the field forward.

8. How does the research published percolate through to practitioners?
The results have important impact on the development of diagnostic kits and vaccine of Lyme disease.

9. What is the purpose of serving as an editor?
Spread the knowledge and improve the quality of journal.

10. Do you have any patents?

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?

12. Do you plan to contribute any editorials or papers to OMICS Journals in the near future?

13. Do you have any trouble with OMICS Journals in the past?

14. Would you recommend OMICS Group to your friends or colleagues?
I did.

15. How do you differentiate Journal of Clinical & Experimental pathology with other journals in the field?
Impact factor.